Affiliation:
1. Department of Human Physiology, School of Laboratory Medicine and Medical Science, College of Health Sciences, University of KwaZulu-Natal, Durban 4041, South Africa
Abstract
Schizophrenia is a debilitating psychiatric disorder comprising positive, negative, and cognitive impairments. Most of the animal models developed to understand the neurobiology and mechanism of schizophrenia do not produce all the symptoms of the disease. Therefore, researchers need to develop new animal models with greater translational reliability, and the ability to produce most if not all symptoms of schizophrenia. This review aimed to evaluate the effectiveness of the rodent “double hit” (post-weaning social isolation and N-methyl-D-aspartate (NMDA) receptor antagonist) model to produce symptoms of schizophrenia. This systematic review was developed according to the 2020 PRISMA guidelines and checklist. The MEDLINE (PubMed) and Ebscohost databases were used to search for studies. The systematic review is based on quantitative animal studies. Studies in languages other than English that could be translated sufficiently using Google translate were also included. Data extraction was performed individually by two independent reviewers and discrepancies between them were resolved by a third reviewer. SYRCLE’s risk-of-bias tool was used to test the quality and biases of included studies. Our primary search yielded a total of 47 articles, through different study selection processes. Seventeen articles met the inclusion criteria for this systematic review. Ten of the seventeen studies found that the “double hit” model was more effective in developing various symptoms of schizophrenia. Most studies showed that the “double hit” model is robust and capable of inducing cognitive impairments and positive symptoms of schizophrenia.
Funder
National Research Foundation
University of KwaZulu-Natal college of health sciences scholarship
Reference61 articles.
1. Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality;McGrath;Epidemiol. Rev.,2008
2. Molecular pathology of schizophrenia: More than one disease process?;Crow;BMJ,1980
3. Symptoms, signs, and diagnosis of schizophrenia;Andreasen;Lancet,1995
4. Cognition in Schizophrenia: Impairments, Determinants, and Functional Importance;Bowie;Psychiatr. Clin. N. Am.,2005
5. Advancing schizophrenia drug discovery: Optimizing rodent models to bridge the translational gap;Pratt;Nat. Rev. Drug Discov.,2012
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献